Formycon AG (XTER:FYB) 3-Year Book Growth Rate : 71.70% (As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Formycon AG 3-Year Book Growth Rate?

Formycon AG's Book Value per Share for the quarter that ended in Jun. 2024 was €32.64.

During the past 12 months, Formycon AG's average Book Value per Share Growth Rate was 22.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 71.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was 55.60% per year. During the past 10 years, the average Book Value per Share Growth Rate was 28.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Formycon AG was 71.70% per year. The lowest was -4.70% per year. And the median was 29.10% per year.

Competitive Comparison of Formycon AG's 3-Year Book Growth Rate

For the Biotechnology subindustry, Formycon AG's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Formycon AG's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Formycon AG's 3-Year Book Growth Rate falls into.

Formycon AG 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Formycon AG (XTER:FYB) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Formycon AG 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Formycon AG's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Formycon AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

0W4N:UK

Address

Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.formycon.com

Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID-19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.

Executives

Dr. Nicola Mikulcik	Board of Directors
Dr. Stefan Glombitza	Board of Directors
Dr. Carsten Brockmeyer	Board of Directors
Dr. Nicolas Combé	Board of Directors

Formycon AG Headlines

No Headlines